Mirum Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MIRM Nasdaq 2830 www.mirumpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Mirum Pharmaceuticals, Inc.

3 Top Growth Stocks to Buy in the First Half of 2026 - Jan 13th, 2026 3:04 am
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 12th, 2026 3:30 pm
Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 - Jan 12th, 2026 9:20 am
Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum - Jan 12th, 2026 6:30 am
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals - Jan 9th, 2026 9:55 am
How Investors May Respond To Mirum Pharmaceuticals (MIRM) Expanding Livmarli And Gaining J.P. Morgan Spotlight - Jan 7th, 2026 10:08 pm
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 7th, 2026 2:01 pm
Should You Invest in Mirum Pharmaceuticals (MIRM)? - Jan 6th, 2026 6:03 am
Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now - Dec 30th, 2025 1:07 am
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line - Dec 28th, 2025 1:31 pm
What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now - Dec 25th, 2025 1:04 pm
This Biotech Name Outperforms 93% Of Stocks, And It's In A Buy Zone - Dec 23rd, 2025 11:51 am
Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX - Dec 19th, 2025 6:30 am
Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition - Dec 11th, 2025 5:44 am
Morgan Stanley Raises Mirum (MIRM) PT to $95 on Strategic Bluejay Acquisition, Brelovitug Pipeline Addition - Dec 11th, 2025 5:44 am
Mirum Pharmaceuticals (MIRM): Assessing Valuation After Strong Long-Term Returns and Recent Share Price Pullback - Dec 11th, 2025 3:16 am
Sector Update: Health Care Stocks Softer Late Afternoon - Dec 9th, 2025 1:59 pm
Mirum Pharmaceuticals price target raised to $130 from $95 at Cantor Fitzgerald - Dec 9th, 2025 7:45 am
Mirum to buy Bluejay for up to $820m in rare liver disease push - Dec 9th, 2025 7:42 am
Mirum to buy Bluejay for up to $820 million in bet on liver-disease drug - Dec 8th, 2025 8:24 am